Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial
Ildiko Lingvay, A. Michael Lincoff, Helen M. Colhoun, John Eric Deanfield et al.
Citations
190 citations
Journal
The Lancet
Topics
Diabetes Treatment and Management
Field-Weighted Citation Impact (FWCI)
67.96
article
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial
Ildiko Lingvay, A. Michael Lincoff, Helen M. Colhoun, John Eric Deanfield, Assen Goudev, Benjamin M. Scirica, Jorge Plutzky, Mikhail Kosiborod, Peter Weeke, G Kees Hovingh, Steven E. Kahn, Chim C. Lang, Søren Hardt‐Lindberg, Subodh Verma, Miguel Urina‐Triana, Ofir Frenkel, Donna H. Ryan, Mikko Pietilä, Scott S. Emerson, Søren Rasmussen
article en
190 citations
Abstract
No abstract available for this paper.
Publication Tag
The LancetVol. 404(10454)
Institutions
Pennington Biomedical Research Center (US), Brigham and Women's Hospital (US), St. Michael's Hospital (CA), Harvard University (US), University of Turku (FI), University of Dundee (GB), University of Toronto (CA), Novo Nordisk (Denmark) (DK), University of Washington (US), Queen Giovanna Hospital (BG), Turku University Hospital (FI), Cleveland Clinic Lerner College of Medicine (US), VA Puget Sound Health Care System (US), Universidad Simón Bolívar (CO), Saint Luke's Hospital (US), Institute of Genetics and Cancer (GB), Case Western Reserve University (US), University of Missouri–Kansas City (US), University of Edinburgh (GB)
Funders
Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, Brigham and Women's Hospital, Alnylam Pharmaceuticals, FibroGen, CSL Behring, Regeneron Pharmaceuticals, TG Therapeutics, Novavax, Intarcia Therapeutics, Amarin Corporation, MannKind Corporation, ReCor Medical, Mylan, BeiGene, Moderna, Insmed, Diabetes UK, European Commission, Novo Nordisk, Shionogi, Servier, H. Lundbeck A/S, Ipsen, Akebia Therapeutics, Esperion Therapeutics, Allergan, Medical Research Council, Daiichi Sankyo Europe